Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FWUVQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,532
Award facts
- Contract value 100% obligated
- $7,531.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program. The contract includes no set-aside designation, allowing the company to compete on a competitive basis leveraging its woman-owned small business status. EXPAREL is a liposomal bupivacaine formulation commonly used for local anesthesia and pain management in surgical and medical applications.
This delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, supporting Department of Defense healthcare requirements. The company's parent IDC with the DLA, valued at $499,999,999 and valid through November 2026, enables the agency to procure an extensive range of pharmaceutical products including prescription medications, biologics, and medical consumables across multiple product categories. The company's performance on this delivery order contributes to fulfilling the broader pharmaceutical supply needs of military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FWUVQ?
SPE2DB25FWUVQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWUVQ worth?
The government has obligated $7,532 on SPE2DB25FWUVQ.
Is contract SPE2DB25FWUVQ an order under another contract?
Yes. SPE2DB25FWUVQ is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUVQ competed?
The extent of competition for SPE2DB25FWUVQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award